Bank of America
BMRN icon

Bank of America’s BioMarin Pharmaceuticals BMRN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$44.1M Buy
801,471
+68,003
+9% +$3.74M ﹤0.01% 1589
2025
Q1
$51.8M Buy
733,468
+225,643
+44% +$16M ﹤0.01% 1378
2024
Q4
$33.4M Sell
507,825
-392,154
-44% -$25.8M ﹤0.01% 1572
2024
Q3
$63.3M Sell
899,979
-123,543
-12% -$8.68M 0.01% 1206
2024
Q2
$84.3M Sell
1,023,522
-1,766,151
-63% -$145M 0.01% 1007
2024
Q1
$244M Buy
2,789,673
+430,808
+18% +$37.6M 0.02% 550
2023
Q4
$227M Sell
2,358,865
-36,356
-2% -$3.51M 0.02% 520
2023
Q3
$212M Sell
2,395,221
-1,264,919
-35% -$112M 0.02% 518
2023
Q2
$317M Buy
3,660,140
+144,310
+4% +$12.5M 0.03% 416
2023
Q1
$342M Buy
3,515,830
+2,370,416
+207% +$230M 0.04% 414
2022
Q4
$119M Sell
1,145,414
-78,091
-6% -$8.08M 0.01% 726
2022
Q3
$104M Buy
1,223,505
+36,884
+3% +$3.13M 0.01% 759
2022
Q2
$98.3M Sell
1,186,621
-19,926
-2% -$1.65M 0.01% 817
2022
Q1
$93M Sell
1,206,547
-457,333
-27% -$35.3M 0.01% 911
2021
Q4
$147M Sell
1,663,880
-45,515
-3% -$4.02M 0.01% 731
2021
Q3
$132M Sell
1,709,395
-1,346
-0.1% -$104K 0.01% 767
2021
Q2
$143M Sell
1,710,741
-156,578
-8% -$13.1M 0.01% 728
2021
Q1
$141M Buy
1,867,319
+55,035
+3% +$4.16M 0.02% 691
2020
Q4
$159M Sell
1,812,284
-67,622
-4% -$5.93M 0.02% 557
2020
Q3
$143M Sell
1,879,906
-390,420
-17% -$29.7M 0.02% 569
2020
Q2
$280M Buy
2,270,326
+171,745
+8% +$21.2M 0.04% 352
2020
Q1
$177M Buy
2,098,581
+344,893
+20% +$29.1M 0.03% 424
2019
Q4
$148M Buy
1,753,688
+161,678
+10% +$13.7M 0.02% 547
2019
Q3
$107M Sell
1,592,010
-257,231
-14% -$17.3M 0.02% 637
2019
Q2
$158M Sell
1,849,241
-57,983
-3% -$4.97M 0.02% 525
2019
Q1
$169M Buy
1,907,224
+91,217
+5% +$8.1M 0.03% 494
2018
Q4
$155M Sell
1,816,007
-193,342
-10% -$16.5M 0.03% 462
2018
Q3
$195M Sell
2,009,349
-208,879
-9% -$20.3M 0.03% 436
2018
Q2
$209M Buy
2,218,228
+438,967
+25% +$41.4M 0.03% 404
2018
Q1
$144M Buy
1,779,261
+72,922
+4% +$5.91M 0.02% 514
2017
Q4
$152M Sell
1,706,339
-501,215
-23% -$44.7M 0.03% 490
2017
Q3
$205M Buy
2,207,554
+149,107
+7% +$13.9M 0.03% 421
2017
Q2
$187M Buy
2,058,447
+198,573
+11% +$18M 0.04% 391
2017
Q1
$163M Buy
1,859,874
+172,225
+10% +$15.1M 0.03% 425
2016
Q4
$140M Buy
1,687,649
+38,362
+2% +$3.18M 0.03% 450
2016
Q3
$153M Buy
1,649,287
+452,382
+38% +$41.9M 0.03% 419
2016
Q2
$93.1M Buy
1,196,905
+158,468
+15% +$12.3M 0.02% 553
2016
Q1
$85.7M Sell
1,038,437
-2,705
-0.3% -$223K 0.02% 585
2015
Q4
$109M Buy
1,041,142
+305,492
+42% +$32M 0.03% 507
2015
Q3
$77.5M Buy
735,650
+207,176
+39% +$21.8M 0.02% 635
2015
Q2
$72.3M Sell
528,474
-44,180
-8% -$6.04M 0.02% 550
2015
Q1
$71.4M Buy
572,654
+18,412
+3% +$2.29M 0.02% 549
2014
Q4
$50.1M Sell
554,242
-33,676
-6% -$3.04M 0.02% 660
2014
Q3
$42.4M Sell
587,918
-25,898
-4% -$1.87M 0.01% 728
2014
Q2
$38.2M Buy
613,816
+64,362
+12% +$4M 0.01% 778
2014
Q1
$37.5M Buy
549,454
+32,245
+6% +$2.2M 0.01% 741
2013
Q4
$36.4M Buy
517,209
+387,764
+300% +$27.3M 0.01% 722
2013
Q3
$9.34M Sell
129,445
-17,282
-12% -$1.25M ﹤0.01% 1419
2013
Q2
$8.18M Buy
+146,727
New +$8.18M ﹤0.01% 1464